Loss of heterozygosity at thymidylate synthase locus in Barrett's metaplasia, dysplasia, and carcinoma sequences

BMC Cancer

Volumn 9, Issue , 2009, Pages

  Kuramochi, Hidekazu ^a,d   Uchida, Kazumi ^a,d   Peters, Jeffery H ^b   Shimizu, Daisuke ^a   Vallbohmer, Daniel ^b,e   Schneider, Sylke ^b   Danenberg, Kathleen D ^c   Danenberg, Peter V ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c Response Genetics Inc   (United States)

^d TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^e UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; THYMIDYLATE SYNTHASE;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; ADENOCARCINOMA; AGED; ARTICLE; BARRETT ESOPHAGUS; BARRETT ESOPHAGUS ASSOCIATED ADENOCARCINOMA; CONTROLLED STUDY; DYSPLASIA; ESOPHAGUS BIOPSY; FEMALE; GASTROESOPHAGEAL REFLUX; GENE EXPRESSION; GENE FREQUENCY; GENE LOCUS; GENE SEQUENCE; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOSITY; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; INTESTINE BIOPSY; INTESTINE DYSPLASIA; INTESTINE METAPLASIA; LASER CAPTURE MICRODISSECTION; MAJOR CLINICAL STUDY; MALE; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; DISEASE COURSE; ESOPHAGUS; GENETICS; HYPERPLASIA; METAPLASIA; MIDDLE AGED; ONCOGENESIS AND MALIGNANT TRANSFORMATION; PATHOLOGY;

ADENOCARCINOMA; AGED; BARRETT ESOPHAGUS; DISEASE PROGRESSION; ESOPHAGUS; FEMALE; HUMANS; HYPERPLASIA; LOSS OF HETEROZYGOSITY; MALE; METAPLASIA; MIDDLE AGED; NEOPLASTIC PROCESSES; THYMIDYLATE SYNTHASE;

EID: 67649818457     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-9-157     Document Type: Article

References (39)

1. Danenberg PV Thymidylate synthetase - a target enzyme in cancer chemotherapy Biochim Biophys Acta 1977, 473:73-92. 145246
2. Leichman CG Lenz HJ Leichman L Danenberg K Baranda J Groshen S Boswell W Metzger R Tan M Danenberg PV Quantitation of intratumoral thymidylate synthase expression predicts for disseminated colorectal cancer response and resistance to protracted-infusion fluorouracil and weekly leucovorin J Clin Oncol 1997, 15:3223-3229. 9336359
3. Salonga D Danenberg KD Johnson M Metzger R Groshen S Tsao-Wei DD Lenz HJ Leichman CG Leichman L Diasio RB Danenberg PV Colorectal tumors responding to 5-fluorouracil have low gene expression levels of dihydropyrimidine dehydrogenase, thymidylate synthase, and thymidine phosphorylase Clin Cancer Res 2000, 6:1322-1327. 10778957
4. Kaneda S Takeishi K Ayusawa D Shimizu K Seno T Altman S Role in translation of a triple tandemly repeated sequence in the 5'-untranslated region of human thymidylate synthase mRNA Nucleic Acids Res 1987, 15:1259-1270. 340522 3029702 10.1093/nar/15.3.1259
5. Ishida Y Kawakami K Tanaka Y Kanehira E Omura K Watanabe G Association of thymidylate synthase gene polymorphism with its mRNA and protein expression and with prognosis in gastric cancer Anticancer Res 2002, 22:2805-2809. 12530000
6. Kawakami K Omura K Kanehira E Watanabe Y Polymorphic tandem repeats in the thymidylate synthase gene is associated with its protein expression in human gastrointestinal cancers Anticancer Res 1999, 19:3249-3252. 10652619
7. Kawakami K Salonga D Park JM Danenberg KD Uetake H Brabender J Omura K Watanabe G Danenberg PV Different lengths of a polymorphic repeat sequence in the thymidylate synthase gene affect translational efficiency but not its gene expression Clin Cancer Res 2001, 7:4096-4101. 11751507
8. Pullarkat ST Stoehlmacher J Ghaderi V Xiong YP Ingles SA Sherrod A Warren R Tsao-Wei D Groshen S Lenz HJ Thymidylate synthase gene polymorphism determines response and oxicity of 5-FU chemotherapy Pharmacogenomics J 2001, 1:65-70. 11913730
9. Kawakami K Watanabe G Identification and functional analysis of single nucleotide polymorphism in the tandem repeat sequence of thymidylate synthase gene Cancer Res 2003, 63:6004-6007. 14522928
10. Mandola MV Stoehlmacher J Muller-Weeks S Cesarone G Yu MC Lenz HJ Ladner RD A novel single nucleotide polymorphism within the 5' tandem repeat polymorphism of the thymidylate synthase gene abolishes USF-1 binding and alters transcriptional activity Cancer Res 2003, 63:2898-2904. 12782596
11. Ulrich CM Bigler J Velicer CM Greene EA Farin FM Potter JD Searching expressed sequence tag databases: Discovery and confirmation of a common polymorphism in the thymidylate synthase gene Cancer Epidemiol Biomarkers Prev 2000, 9:1381-1385. 11142426
12. Mandola MV Stoehlmacher J Zhang W Groshen S Yu MC Iqbal S Lenz HJ Ladner RD A 6 bp polymorphism in the thymidylate synthase gene causes message instability and is associated with decreased intratumoral TS mRNA levels Pharmacogenetics 2004, 14:319-327. 10.1097/00008571-200405000-00007 15115918
13. Uchida K Hayashi K Kawakami K Schneider S Yochim JM Kuramochi H Takasaki K Danenberg KD Danenberg PV Loss of heterozygosity at the thymidylate synthase (TS) locus on chromosome 18 affects tumor response and survival in individuals heterozygous for a 28-bp polymorphism in the TS gene Clin Cancer Res 2004, 10:433-439. 10.1158/1078-0432.CCR-0200-03 14760062
14. Phillips RW Wong RK Barrett's esophagus. Natural history, incidence, etiology, and complications Gastroenterol Clin North Am 1991, 20:791-816. 1787014
15. Souza RF Meltzer SJ The molecular basis for carcinogenesis in metaplastic columnar-lined esophagus Gastroenterol Clin North Am 1997, 26:583-597. 10.1016/S0889-8553(05)70315-0 9309406
16. Gleeson CM Sloan JM McGuigan JA Ritchie AJ Weber JL Russell SE Barrett's oesophagus: Microsatellite analysis provides evidence to support the proposed metaplasia-dysplasia-carcinoma sequence Genes Chromosomes Cancer 1998, 21:49-60. 10.1002/ (SICI)1098-2264(199801)21:1<49::AID-GCC7>3.0.CO;2-8 9443041
17. Drewitz DJ Sampliner RE Garewal HS The incidence of adenocarcinoma in Barrett's esophagus: A prospective study of 170 patients followed 4.8 years Am J Gastroenterol 1997, 92:212-215. 9040193
18. O'Connor JB Falk GW Richter JE The incidence of adenocarcinoma and dysplasia in Barrett's esophagus: Report on the Cleveland Clinic Barrett's Esophagus Registry Am J Gastroenterol 1999, 94:2037-2042. 10445525
19. Miros M Kerlin P Walker N Only patients with dysplasia progress to adenocarcinoma in Barrett's oesophagus Gut 1991, 32:1441-1446. 1379239 1773946 10.1136/gut.32.12.1441
20. Galipeau PC Prevo LJ Sanchez CA Longton GM Reid BJ Clonal expansion and loss of heterozygosity at chromosomes 9p and 17p in premalignant esophageal (Barrett's) tissue J Natl Cancer Inst 1999, 91:2087-2095. 1559996 10601379 10.1093/jnci/91.24.2087
21. Kuramochi H Tanaka K Oh D Lehman BJ Dunst CM Yang DY De Meester SR Hagen JA Danenberg KD De Meester TR Danenberg PV Thymidylate synthase polymorphisms and mRNA expression are independent chemotherapy predictive markers in esophageal adenocarcinoma patients Int J Oncol 2008, 32:201-208. 18097560
22. Bonner RF Emmert-Buck M Cole K Pohida T Chuaqui R Goldstein S Liotta LA Laser capture microdissection: Molecular analysis of tissue Science 1997, 278:1481-1483. 10.1126/science.278.5342.1481 9411767
23. Kuramochi H Vallbohmer D Uchida K Schneider S Hamoui N Shimizu D Chandrasoma PT DeMeester TR Danenberg KD Danenberg PV Peters JH Quantitative, tissue-specific analysis of cyclooxygenase gene expression in the pathogenesis of Barrett's adenocarcinoma J Gastrointest Surg 2004, 8:1007-1016. discussion 1016-1007 10.1016/j.gassur.2004.09.025 15585388
24. Lord RV Salonga D Danenberg KD Peters JH DeMeester TR Park JM Johansson J Skinner KA Chandrasoma P DeMeester SR Telomerase reverse transcriptase expression is increased early in the Barrett's metaplasia, dysplasia, adenocarcinoma sequence J Gastrointest Surg 2000, 4:135-142. 10.1016/ S1091-255X(00)80049-9 10675236
25. Gibson UE Heid CA Williams PM A novel method for real time quantitative RT-PCR Genome Res 1996, 6:995-1001. 10.1101/gr.6.10.995 8908519
26. Heid CA Stevens J Livak KJ Williams PM Real time quantitative PCR Genome Res 1996, 6:986-994. 10.1101/gr.6.10.986 8908518
27. Suspiro A Pereira AD Afonso A Albuquerque C Chaves P Soares J Leitao CN Losses of heterozygosity on chromosomes 9p and 17p are frequent events in Barrett's metaplasia not associated with dysplasia or adenocarcinoma Am J Gastroenterol 2003, 98:728-734. 10.1111/j.1572-0241.2003.07411.x 12738448
28. Wu TT Watanabe T Heitmiller R Zahurak M Forastiere AA Hamilton SR Genetic alterations in Barrett esophagus and adenocarcinomas of the esophagus and esophagogastric junction region Am J Pathol 1998, 153:287-294. 1852949 9665490
29. Wong DJ Paulson TG Prevo LJ Galipeau PC Longton G Blount PL Reid BJ p16(INK4a) lesions are common, early abnormalities that undergo clonal expansion in Barrett's metaplastic epithelium Cancer Res 2001, 61:8284-8289. 11719461
30. Muzeau F Flejou JF Thomas G Hamelin R Loss of heterozygosity on chromosome 9 and p16 (MTS1, CDKN2) gene mutations in esophageal cancers Int J Cancer 1997, 72:27-30. 10.1002/ (SICI)1097-0215(19970703)72:1<27::AID-IJC3>3.0.CO;2-6 9212218
31. Reid BJ Prevo LJ Galipeau PC Sanchez CA Longton G Levine DS Blount PL Rabinovitch PS Predictors of progression in Barrett's esophagus II: baseline 17p (p53) loss of heterozygosity identifies a patient subset at increased risk for neoplastic progression Am J Gastroenterol 2001, 96:2839-2848. 1808263 11693316 10.1111/j.1572-0241.2001.04236.x
32. Huang Y Boynton RF Blount PL Silverstein RJ Yin J Tong Y Loss of heterozygosity involves multiple tumor suppressor genes in human esophageal cancers Cancer Res 1992, 52:6525-6530. 1423299
33. Kulke MH Odze RD Thakore KS Thomas G Wang H Loda M Eng C Allelic loss of 10q23, the PTEN tumour suppressor gene locus, in Barrett's oesophagus-associated adenocarcinoma Br J Cancer 2001, 84:748-753. 10.1054/bjoc.2000.1660 11259087
34. Zhuang Z Vortmeyer AO Mark EJ Odze R Emmert-Buck MR Merino MJ Moon H Liotta LA Duray PH Barrett's esophagus: Metaplastic cells with loss of heterozygosity at the APC gene locus are clonal precursors to invasive adenocarcinoma Cancer Res 1996, 56:1961-1964. 8616831
35. van Dekken H Vissers CJ Tilanus HW Tanke HJ Rosenberg C Clonal analysis of a case of multifocal oesophageal (Barrett's) adenocarcinoma by comparative genomic hybridization J Pathol 1999, 188:263-266. 10.1002/ (SICI)1096-9896(199907)188:3<263::AID-PATH374>3.0.CO;2-Y 10419593
36. Owonikoko T Rees M Gabbert HE Sarbia M Intratumoral genetic heterogeneity in Barrett adenocarcinoma Am J Clin Pathol 2002, 117:558-566. 10.1309/6XY8-FMM5-VVCJ-T3N0 11939730
37. Tran Y Benbatoul K Gorse K Rempel S Futreal A Green M Newsham I Novel regions of allelic deletion on chromosome 18p in tumors of the lung, brain and breast Oncogene 1998, 17:3499-3505. 10.1038/sj.onc.1202258 10030674
38. Morganti M Ciantelli M Giglioni B Putignano AL Nobili S Papi L Landini I Napoli C Valanzano R Cianchi F et al. Relationships between promoter polymorphisms in the thymidylate synthase gene and mRNA levels in colorectal cancers Eur J Cancer 2005, 41:2176-2183. 10.1016/ j.ejca.2005.06.016 16182121
39. Merkelbach-Bruse S Hans V Mathiak M Sanguedolce R Alessandro R Ruschoff J Buttner R Houshdaran F Gullotti L Associations between polymorphisms in the thymidylate synthase gene, the expression of thymidylate synthase mRNA and the microsatellite instability phenotype of colorectal cancer Oncol Rep 2004, 11:839-843. 15010882